insights_auto
Why is PRME down 11.58%?
Dive Deeperchevron_right
PRME:NASDAQ
Prime Medicine, Inc
$3.13
arrow_downward
-11.58%(-0.41) 1D
$3.13
0.00% (0.00)
todayPre-market
Closed: Sep 23, 4:00:00 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PRME...
Open
$3.53
High
$3.53
Low
$3.12
Mkt. cap
567.71M
Avg. vol.
2.72M
Volume
305.00
52-wk high
$6.94
52-wk low
$2.67
EPS
-$1.09
Beta
2.34
Shares outstanding
181.38M
No. of employees
146
Open
$3.53
High
$3.53
Low
$3.12
Mkt. cap
567.71M
Avg. vol.
2.72M
Volume
305.00
52-wk high
$6.94
52-wk low
$2.67
EPS
-$1.09
Beta
2.34
Shares outstanding
181.38M
No. of employees
146
News stories
From web sources and news partners
TradingView
·
11 hours ago
CRSP, NTLA, BEAM, PRME, EDIT Shares Slip — Did Claude Just Spook Gene-Editing Stocks?
MarketBeat
·
14 hours ago
Prime Medicine (NASDAQ:PRME) Stock Price Down 7.5% - Should You Sell?
Profile
Prime Medicine, Inc. is an American biotechnology company developing gene therapies based on prime editing. The company is headquartered in Cambridge, Massachusetts. Wikipedia
About Prime Medicine, Inc